Loading
Latest filing published 14 Sept 2018 for Avivagen Inc., €3,697.
No signal scores available.
David Curtis Hankinson appears in our data through filings on Avivagen Inc. shares, published by SEDI. Over a trading history stretching from 12 May 2017 to 11 September 2018, the count stands at 3 filings.
Purchases make up the whole of the open-market record (1 purchase, €3,697). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2018: 1 purchase and no sales on the market.
The record was last updated on 14 September 2018 with an open-market purchase (€3,697) in Avivagen Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations